CalciMedica, Inc.
CALC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.01 | 0.59 | 0.00 |
| FCF Yield | -53.14% | -200.97% | -131.20% | -361.73% |
| EV / EBITDA | -1.32 | -0.19 | -1.70 | 0.13 |
| Quality | ||||
| ROIC | -150.24% | -466.78% | 1,155.78% | -55.28% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.54 | 0.75 | 1.50 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 18.03% | -119.44% | 63.23% | 3.32% |
| Safety | ||||
| Net Debt / EBITDA | 0.33 | 0.15 | -0.53 | 0.38 |
| Interest Coverage | 0.00 | -346.14 | -107.52 | -285.29 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -24.71 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -385.39 |